Skip to content
DraconiticResearch
Search Sources API
220,430 studies31 sourcesUpdated 38 min ago

Oncology

5,770 studies495 in 7 days2,675 in 30 days

Filters
Type
Date
Clear

Latest

5,770 studies

  1. Development and Optimization of 111In-Dinutuximab-IRDye800, a Dual-Modality Intraoperative Molecular Imaging Agent for Pediatric Neuroblastoma Resection
    C. Y. Yip, L. T. Rosenblum, A. Pant +13
    bioRxivPreprintCC BYFull textOncologybioRxiv
  2. Non-inferior survival and enhanced longevity with initial low-dose versus full-dose enzalutamide: a single-centre real-world prostate cancer study
    O. Gorobets, V. Vinh-Hung
    medRxivPreprintCC BY-NC-NDFull textOncologymedRxiv
  3. Bidirectional Regulation of c-Myc and TRB1 Establishes Oncogenic Reciprocal Regulation
    Yuya Suzuki, Mai Nagasaka, Chiharu Miyajima +9
    Biological and Pharmaceutical BulletinPeer-reviewedCC BY-NCFull textOncologyJ-STAGE
  4. Disruption of the interferon-gamma axis limits chimeric antigen receptor T cell efficacy against acute myeloid leukemia
    N. Murren, I. King, L. Mahoney +6
    bioRxivPreprintAll rights reservedFull textOncologybioRxiv
  5. In silico engineered multitarget-directed ligands for the polypharmaceutical treatment of PTEN loss of function endometrial adenocarcinoma
    R. Delara, V. Mujumdar, Q. Zhang +15
    bioRxivPreprintAll rights reservedFull textOncologybioRxiv
  6. Melatonin nanoparticles inhibit mutant hematopoiesis and restore bone marrow architecture in myeloproliferative neoplasms
    S. Gupta, A. Motta, S. Elsafy +25
    bioRxivPreprintCC BY-NC-NDFull textOncologybioRxiv
  7. BCL2L13 attenuation links impaired mitophagy to epithelial plasticity and anoikis tolerance in lung adenocarcinoma
    J. Alizadeh, S. Rosa, A. Srivastava +13
    bioRxivPreprintCC BY-NC-NDFull textOncologybioRxiv
  8. A conditional, myeloid-cell specific estrogen receptor α deletion reprograms the liver immune microenvironment and impedes the growth of colon carcinoma liver metastases
    O. Hacariz, M. Kalaw, Q. Yang +2
    bioRxivPreprintAll rights reservedFull textOncologybioRxiv
  9. TNIK maintains a MYC-driven partial EMT state that supports proliferation and evasion of senescence in lung squamous cell carcinoma.
    P. Torres-Ayuso, M. Hamidi, K. O. Omolo +3
    bioRxivPreprintAll rights reservedFull textOncologybioRxiv
  10. Metastatic founder cell candidates resemble preimplantation embryonic blastomeres
    C. A. Klein, H. Koerkel-Qu, E. Raya +22
    bioRxivPreprintCC BYFull textOncologybioRxiv
  11. On-treatment core needle biopsy identifies early responders for axillary surgery de-escalation: results from a prospective cohort
    Yifan Xie, Siyu Wu, Yan Huang +5
    British Journal of CancerPeer-reviewedLicence not statedFull textOncologyPMC
  12. Premature cancer mortality in China based on cancer registry☆
    Bingfeng Han, Rongshou Zheng, Hongmei Zeng +8
    Journal of the National Cancer CenterPeer-reviewedCC BY-NC-ND 4.0Full textOncologyPMC
  13. A Phase I First-Time-in-Human, Open-label Study of Nelistotug Administered to Patients with Advanced Solid Tumors
    Lillian L. Siu, Omid Hamid, Reva Schneider +16
    Clinical Cancer ResearchPeer-reviewedCC BY 4.0Full textOncologyPMC
  14. Liquid biopsy in solid tumours: expert opinion paper of the European society of pathology
    Nicola Fusco, Xavier Matias-Guiu, Irene Esposito +3
    Virchows ArchivPeer-reviewedCC BY-NC-ND 4.0Full text1 citedOncologyPMC
  15. Proteinuria as the cause of early dose modification in Japanese patients with metastatic colorectal cancer treated with fruquintinib: a multicenter real-world study
    Shohei Udagawa, Chihiro Ishizuka, Hiroki Osumi +15
    International Journal of Clinical OncologyPeer-reviewedCC BY 4.0Full textOncologyPMC
  16. Functional spatial transcriptomics uncover LMO7 as a fusion-regulated and clinically relevant driver of metastasis in Ewing sarcoma
    V. Bursic, H. Luo, C. Henon +15
    bioRxivPreprintCC BY-NC-NDFull textOncologybioRxiv
  17. The Anti-Cancer Effects of Selected Indigenous Medicinal Plants of the Arid Bioregion
    F. W. Muema, S. Thompson, G. Turpin +6
    bioRxivPreprintCC BY-NC-NDFull textOncologybioRxiv
  18. Genome Profiling of Actionable Cancer Targets (NYU LG-PACT) for Clinical Patient Molecular Diagnostics and Treatment
    Y. Yang, V. Vasudevaraja, J. Serrano +13
    medRxivPreprintAll rights reservedFull textOncologymedRxiv
  19. Lymphodepletion mitigates anti-CAR immunity in pediatric and young adult patients with recurrent or refractory brain tumors: clinical trial results
    L. D. Wang, A. M. T. Oill, S. E. Lindner +39
    medRxivPreprintCC BY-NCFull textOncologymedRxiv
  20. Identification of miR-615-5p/ID1 axis crucial in the pathogenesis of pancreatic ductal adenocarcinoma (PDAC)
    A. Sarkar, S. Ray, A. Ray +1
    bioRxivPreprintAll rights reservedFull textOncologybioRxiv
  21. Spatial transcriptomics reveals site-specific cellular and metabolic heterogeneity in bladder carcinoma in situ
    T. Myers, A. Salmasi, M. F. Meagher +10
    bioRxivPreprintCC BY-NCFull textOncologybioRxiv
  22. Txn-Txnrd1 system supports redox rewiring during polyaneuploid transition and protects giant cancer cells at new redox homeostasis
    K. Kolacz-Milewska, K. Gronkowska, S. Michlewska +3
    bioRxivPreprintCC BY-NC-NDFull textOncologybioRxiv
  23. Real‐world outcomes of ide‐cel and cilta‐cel in relapsed/refractory multiple myeloma: A nationwide, retrospective analysis in Austria
    Irene Strassl, Alexander Nikoloudis, Lina Zoe Ruesing +21
    British Journal of HaematologyPeer-reviewedCC BY-NC 4.0Full textOncologyPMC
  24. A PTBP1–CDC42 splicing axis regulates leukemia growth and venetoclax sensitivity in acute myeloid leukemia
    Margaux Oberling, Mathieu Landry, Yann Aubert +16
    HALPreprintCC BY-NC-ND 4.0Full textOncologyHAL
  25. Risk prediction model for brain metastasis risk among patients diagnosed with primary gastrointestinal cancers
    Marc Vincent N. Barcelona, Kaushik Jagannath Kataki, Fadwa Abdel Rahman +11
    British Journal of CancerPeer-reviewedLicence not statedFull textOncologyPMC